Literature DB >> 2005882

The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.

L Naldini1, E Vigna, R Ferracini, P Longati, L Gandino, M Prat, P M Comoglio.   

Abstract

Protein tyrosine kinases are crucially involved in the control of cell proliferation. Therefore, the regulation of their activity in both normal and neoplastic cells has been under intense scrutiny. The product of the MET oncogene is a transmembrane receptorlike tyrosine kinase with a unique disulfide-linked heterodimeric structure. Here we show that the tyrosine kinase activity of the MET-encoded protein is powerfully activated by tyrosine autophosphorylation. The enhancement of activity was quantitated with a phosphorylation assay of exogenous substrates. It involved an increase in the Vmax of the enzyme-catalyzed phosphotransfer reaction. No change was observed in the Km (substrate). A causal relationship between tyrosine autophosphorylation and activation of the kinase activity was proved by (i) the kinetic agreement between autophosphorylation and kinase activation, (ii) the overlapping dose-response relationship for ATP, (iii) the specificity for ATP of the activation process, (iv) the phosphorylation of tyrosine residues only, in the Met protein, in the activation step, (v) the linear dependence of the activation from the input of enzyme assayed, and (vi) the reversal of the active state by phosphatase treatment. Autophosphorylation occurred predominantly on a single tryptic peptide, most likely via an intermolecular reaction. The structural features responsible for this positive modulation of kinase activity were all contained in the 45-kDa intracellular moiety of the Met protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005882      PMCID: PMC359847          DOI: 10.1128/mcb.11.4.1793-1803.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

Authors:  C A Cartwright; W Eckhart; S Simon; P L Kaplan
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

2.  Mechanism of met oncogene activation.

Authors:  M Park; M Dean; C S Cooper; M Schmidt; S J O'Brien; D G Blair; G F Vande Woude
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

3.  Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation.

Authors:  R Herrera; O M Rosen
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

4.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

5.  Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src.

Authors:  H Piwnica-Worms; K B Saunders; T M Roberts; A E Smith; S H Cheng
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

6.  The activated human met gene encodes a protein tyrosine kinase.

Authors:  P R Tempest; C S Cooper; G N Major
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

7.  Insulin stimulation of the insulin receptor kinase can occur in the complete absence of beta subunit autophosphorylation.

Authors:  B D Morrison; J E Pessin
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

8.  The kinetics of tyrosine phosphorylation by the purified epidermal growth factor receptor kinase of A-431 cells.

Authors:  C Erneux; S Cohen; D L Garbers
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

9.  Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells.

Authors:  L Naldini; A Stacchini; D M Cirillo; M Aglietta; F Gavosto; P M Comoglio
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

10.  Enzymatic activation of Fujinami sarcoma virus gag-fps transforming proteins by autophosphorylation at tyrosine.

Authors:  K Meckling-Hansen; R Nelson; P Branton; T Pawson
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  49 in total

Review 1.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Activating mutations for the met tyrosine kinase receptor in human cancer.

Authors:  M Jeffers; L Schmidt; N Nakaigawa; C P Webb; G Weirich; T Kishida; B Zbar; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.

Authors:  V Wallenius; M Hisaoka; K Helou; G Levan; N Mandahl; J M Meis-Kindblom; L G Kindblom; J O Jansson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).

Authors:  A Mondino; S Giordano; P M Comoglio
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

5.  C-terminal truncated forms of Met, the hepatocyte growth factor receptor.

Authors:  M Prat; T Crepaldi; L Gandino; S Giordano; P Longati; P Comoglio
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

6.  Promise and challenges on the horizon of MET-targeted cancer therapeutics.

Authors:  Yu-Wen Zhang
Journal:  World J Biol Chem       Date:  2015-05-26

7.  Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor.

Authors:  R Wang; R Kobayashi; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

8.  Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion.

Authors:  Hannah Johnson; Rebecca S Lescarbeau; Jesus A Gutierrez; Forest M White
Journal:  J Proteome Res       Date:  2013-03-11       Impact factor: 4.466

9.  Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.

Authors:  A Nusrat; C A Parkos; A E Bacarra; P J Godowski; C Delp-Archer; E M Rosen; J L Madara
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.

Authors:  Nikolaus Schiering; Stefan Knapp; Marina Marconi; Maria M Flocco; Jean Cui; Rita Perego; Luisa Rusconi; Cinzia Cristiani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.